Evonile Pharma Plans ₹9,000 Million Rights Issue

Evonile Pharma Ltd's Board of Directors has approved a Rights Issue to raise up to ₹9,000 million (Rupees Nine Thousand Million). The funds will be raised through the issuance of partly paid up equity shares to eligible shareholders. A 'Rights Issue Committee' has been authorized to determine the specific terms, including the record date, issue price, and entitlement ratio. The Board also approved the payment schedule, utilization of proceeds, and the Letter of Offer for filing with regulatory bodies and dispatch to shareholders.